SciELO - Scientific Electronic Library Online

 
vol.61 issue2Financial impact of antibiotic therapy face to bacterial multiresistance in emergency hospital in Pernambuco, BrazilStability in the magnetic relaxation time of the CM-95 solution author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Ars Pharmaceutica (Internet)

On-line version ISSN 2340-9894

Abstract

BURGUET-LAGO, Nancy et al. Technological development of sodium heparin injection in solution of 5.000 IU/mL. Ars Pharm [online]. 2020, vol.61, n.2, pp.127-133.  Epub July 20, 2020. ISSN 2340-9894.  http://dx.doi.org/10.30827/ars.v61i2.12208.

Objective:

Developing a new formulation of heparin sodium injection in solution of 5.000 IU/mL.

Methods:

Three variants of formulations were tested and three batches were prepared at laboratory scale. Three pilot batches were also scaled up with stability checking for 12 months of shelf life and 6 months accelerated.

Results:

The formulation composed of heparin sodium (5.000 IU/mL), chlorobutanol as preserve, two buffers (monobasic sodium phosphate/dibasic sodium phosphate) and water for injection, as a vehicle; 6R bulbs, transparent and colorless, met the quality requirements. Biological potency and pH control were stable in the three batches prepared at laboratory scale.

Conclusions:

The results obtained in the latter demonstrated the feasibility of the technological development of this medicine, fulfilling the quality characteristics of the injectables.

Keywords : Sodium heparin; Injectable; Development.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )